Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-25-000112

Options or other derivatives

  • Chief Accounting Officer acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Seymour June Ann Chief Accounting Officer 2025-10-27 Grant or award · Employee Stock Option (right to buy) +50,000 50,000 D: show line 1 in the form
Loading xslF345X05/wk-form4_1761681948.xml…